Tekla Life Sciences Stock Current Valuation
| HQL Stock | USD 12.79 0.03 0.23% |
Valuation analysis of Tekla Life Sciences helps investors to measure Tekla Life's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Tekla Life's Enterprise Value Over EBITDA is quite stable compared to the past year. Enterprise Value Multiple is expected to rise to 18.05 this year, although Enterprise Value will most likely fall to about 275.3 M. Fundamental drivers impacting Tekla Life's valuation include:
Price Book 0.8672 | Enterprise Value 345.4 M | Price Sales 99.2205 | Trailing PE 16.2278 |
Fairly Valued
Today
Please note that Tekla Life's price fluctuation is very steady at this time. Calculation of the real value of Tekla Life Sciences is based on 3 months time horizon. Increasing Tekla Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Tekla Life Sciences is useful when determining the fair value of the Tekla stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Tekla Life. Since Tekla Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Stock. However, Tekla Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.79 | Real 13.11 | Hype 12.81 |
The real value of Tekla Stock, also known as its intrinsic value, is the underlying worth of Tekla Life Sciences Company, which is reflected in its stock price. It is based on Tekla Life's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Tekla Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tekla Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tekla Life Sciences helps investors to forecast how Tekla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Life more accurately as focusing exclusively on Tekla Life's fundamentals will not take into account other important factors: Tekla Life Sciences Company Current Valuation Analysis
Tekla Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Tekla Life Current Valuation | 345.37 M |
Most of Tekla Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tekla Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Tekla Life is extremely important. It helps to project a fair market value of Tekla Stock properly, considering its historical fundamentals such as Current Valuation. Since Tekla Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tekla Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tekla Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Tekla Current Valuation Historical Pattern
Today, most investors in Tekla Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tekla Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tekla Life current valuation as a starting point in their analysis.
Tekla Life Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Tekla Life Sciences has a Current Valuation of 345.37 M. This is 98.95% lower than that of the Capital Markets sector and 95.38% lower than that of the Financials industry. The current valuation for all United States stocks is 97.92% higher than that of the company.
Tekla Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tekla Life could also be used in its relative valuation, which is a method of valuing Tekla Life by comparing valuation metrics of similar companies.Tekla Life is currently under evaluation in current valuation category among related companies.
Tekla Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tekla Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tekla Life's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Tekla Fundamentals
| Return On Equity | 0.0128 | |||
| Return On Asset | -0.0032 | |||
| Profit Margin | 1.56 % | |||
| Operating Margin | (0.49) % | |||
| Current Valuation | 345.37 M | |||
| Shares Outstanding | 26.79 M | |||
| Shares Owned By Institutions | 34.02 % | |||
| Number Of Shares Shorted | 21.32 K | |||
| Price To Earning | 2.84 X | |||
| Price To Book | 0.87 X | |||
| Price To Sales | 99.22 X | |||
| Revenue | 23.52 M | |||
| Gross Profit | 3.02 M | |||
| EBITDA | 22.35 M | |||
| Net Income | 22.35 M | |||
| Cash And Equivalents | 292.4 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 1.34 X | |||
| Book Value Per Share | 16.12 X | |||
| Cash Flow From Operations | (12.8 M) | |||
| Short Ratio | 0.34 X | |||
| Earnings Per Share | 0.79 X | |||
| Beta | 0.72 | |||
| Market Capitalization | 343.46 M | |||
| Total Asset | 402.6 M | |||
| Retained Earnings | (1.48 M) | |||
| Annual Yield | 0.10 % | |||
| Five Year Return | 8.83 % | |||
| Net Asset | 402.6 M | |||
| Last Dividend Paid | 1.3 |
About Tekla Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tekla Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tekla Life's short interest history, or implied volatility extrapolated from Tekla Life options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Tekla Life Piotroski F Score and Tekla Life Altman Z Score analysis. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Tekla Stock analysis
When running Tekla Life's price analysis, check to measure Tekla Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Life is operating at the current time. Most of Tekla Life's value examination focuses on studying past and present price action to predict the probability of Tekla Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Life's price. Additionally, you may evaluate how the addition of Tekla Life to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Tekla Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Dividend Share 1.3 | Earnings Share 0.79 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.344 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.